Hold your needles in women with recurrent pregnancy losses with or without hereditary thrombophilia: Meta-analysis and review of the literature

Davenport, 2014, Inherited thrombophilias and adverse pregnancy outcomes: a review of screening patterns and recommendations, Obstet Gynecol Clin North Am, 41, 133, 10.1016/j.ogc.2013.10.005 Rasmark Roepke, 2018, Treatment efficacy for idiopathic recurrent pregnancy loss - a systematic review and meta-analyses, Acta Obstet Gynecol Scand, 10.1111/aogs.13352 Skeith, 2016, A meta-analysis of low-molecular-weight heparin to prevent pregnancy loss in women with inherited thrombophilia, Blood, 127, 1650, 10.1182/blood-2015-12-626739 Laskin, 2009, Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial, J Rheumatol, 36, 279, 10.3899/jrheum.080763 Bennett, 2012, Pregnancy loss and thrombophilia: the elusive link, Br J Haematol, 157, 529, 10.1111/j.1365-2141.2012.09112.x Badawy, 2008, Low-molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology, J Obstet Gynaecol, 28, 280, 10.1080/01443610802042688 Dolitzky, 2006, A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages, Fertil Steril, 86, 362, 10.1016/j.fertnstert.2005.12.068 Fawzy, 2008, Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study, Arch Gynecol Obstet, 278, 33, 10.1007/s00404-007-0527-x Giancotti, 2012, Efficacy of three different antithrombotic regimens on pregnancy outcome in pregnant women affected by recurrent pregnancy loss, J Matern Fetal Neonatal Med, 25, 1191, 10.3109/14767058.2011.600366 Shaaban, 2017, Low-molecular-weight heparin for the treatment of unexplained recurrent miscarriage with negative antiphospholipid antibodies: a randomized controlled trial, Clin Appl Thromb Hemost, 23, 567, 10.1177/1076029616665167 Kaandorp, 2010, Aspirin plus heparin or aspirin alone in women with recurrent miscarriage, N Engl J Med, 362, 1586, 10.1056/NEJMoa1000641 Pasquier, 2015, Enoxaparin for prevention of unexplained recurrent miscarriage: a multicenter randomized double-blind placebo-controlled trial, Blood, 125, 2200, 10.1182/blood-2014-11-610857 Schleussner, 2015, Low-molecular-weight heparin for women with unexplained recurrent pregnancy loss: a multicenter trial with a minimization randomization scheme, Ann Intern Med, 162, 601, 10.7326/M14-2062 Gris, 2004, Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder, Blood, 103, 3695, 10.1182/blood-2003-12-4250 Rodger, 2014, Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial, Lancet, 384, 1673, 10.1016/S0140-6736(14)60793-5 Clark, 2010, SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage, Blood, 115, 4162, 10.1182/blood-2010-01-267252 Visser, 2011, Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial, Thromb Haemost, 105, 295, 10.1160/TH10-05-0334 Higgins, 2002, Quantifying heterogeneity in a meta-analysis, Stat Med, 21, 1539, 10.1002/sim.1186 Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629 Jadad, 1996, Assessing the quality of reports of randomized clinical trials: is blinding necessary?, Control Clin Trials, 17, 1, 10.1016/0197-2456(95)00134-4 Higgins, 2011, The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials, BMJ, 343, d5928, 10.1136/bmj.d5928 Liberati, 2009, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration, J Clin Epidemiol, 62, e1, 10.1016/j.jclinepi.2009.06.006 Folkeringa, 2007, Reduction of high fetal loss rate by anticoagulant treatment during pregnancy in antithrombin, protein C or protein S deficient women, Br J Haematol, 136, 656, 10.1111/j.1365-2141.2006.06480.x Shinozaki, 2016, Protein S deficiency complicated pregnancy in women with recurrent pregnancy loss, Gynecol Endocrinol, 32, 672, 10.3109/09513590.2016.1152239 Silver, 2010, Prothrombin gene G20210A mutation and obstetric complications, Obstet Gynecol, 115, 14, 10.1097/AOG.0b013e3181c88918 Karadag, 2019, Aspirin, low molecular weight heparin, or both in preventing pregnancy complications in women with recurrent pregnancy loss and factor V Leiden mutation, J Matern Fetal Neonatal Med, 1 Rogenhofer, 2017, Lessons from the EThIGII trial: proper putative benefit assessment of low-molecular-weight heparin treatment in M2/ANXA5 haplotype carriers, Clin Appl Thromb Hemost, 23, 27, 10.1177/1076029616658117